# Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia

> **NCT05944510** · PHASE4 · COMPLETED · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 40 (actual)

## Conditions studied

- Treatment Resistant Schizophrenia

## Interventions

- **DRUG:** Dextromethorphan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05944510
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-31
- **Primary completion:** 2024-10-15
- **Final completion:** 2025-04-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05944510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05944510, "Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT05944510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*